Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity

NCT00057460 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Healthy

Interventions

DRUG: Talampanel

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)